XM does not provide services to residents of the United States of America.

Indian shares set for tepid start ahead of US inflation data



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares set for tepid start ahead of US inflation data</title></head><body>

BENGALURU, May 29 (Reuters) -Indian shares are likely to start trade on a lacklustre note on Wednesday, tracking weakness in global peers, as investors cautiously await U.S. inflation data due this week for clues on the Federal Reserve's interest rate trajectory.

The Gift Nifty GIFc1 was trading at 22,821, as of 0814 a.m. IST, indicating that the Nifty 50 .NSEI will open slightly higher than its previous close of 22,888.15.

Recent U.S. data kept traders guessing about the strength of the economy and sticky inflationary pressures, which in turn cloud the outlook for the Fed's policy path. MKTS/GLOB

Asian peers were trading lower, with the MSCI Asia ex-Japan .MIAPJ0000PUS falling 0.89%.

"Global markets are consolidating ahead of U.S. GDP data and core PCE data, releasing on May 30, which will be crucial indicator for U.S. Fed interest rate decision," said Siddhartha Khemka, head - Retail Research, Motilal Oswal Financial Services.

"Expect Nifty to remain sideways to marginally positive on the back of reduced FII selling, prediction of above-normal monsoon and last leg of Q4 results," Khemka said.

Indian benchmarks ended lower on Tuesday in another volatile session with nervousness around the outcome of the national general elections next week.

Foreign investors were net sellers on Tuesday, offloading shares worth 655.7 million rupees ($7.88 million), while domestic institutional investors bought 32.32 billion rupees in stocks.


STOCKS TO WATCH


Key earnings: Tata Steel TISC.NS, Bata India BATA.NS and Cummins India CUMM.NS

Hindalco Industries HALC.NS: Aluminium recycler Novelis, owned by the company, is targeting a valuation of up to $12.6 billion in its initial public offering in the United States.

Reliance Industries RELI.NS: The company has signed one-year deal with Russia's Rosneft to buy at least 3 million barrels of oil a month in roubles, four sources aware of the matter told Reuters.


($1 = 83.2010 Indian rupees)





Reporting by Dimpal Gulwani in Bengaluru; Editing by Sherry Jacob-Phillips

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.